Cytotherapy. 2006;8(5):427-36.

Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans.

Source

Department of Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. peggsk@mskcc.org

Abstract

Allogeneic hematopoietic stem cell transplantation is a potentially curative treatment modality for a number of hematologic malignancies, as well as inherited immunodeficiencies and hemoglobinopathies, and may also have a role in selected acquired autoimmune disorders. The complete or near-complete ablation of host immunity and subsequent establishment of donor-derived immunity that is required for successful engraftment and long-term outcomes provide a major obstacle to such transplantation approaches. A delicate balance exists between the need for the reconstituted donor-derived immunity to provide both protection against pathogenic challenges and graft-versus-malignancy activity, and the potentially harmful expansion of alloreactive T-cell clones mediating GvHD. The search for interventions that would allow more rapid and selective reconstitution of beneficial immune specificities continues to be informed by the development of new tools enabling a more precise dissection of the kinetics of reconstituting populations. This review summarizes more recent data on immune reconstitution following allogeneic transplantation in humans.

PMID:: 17050247; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Review Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. [Dan Med Bull. 2007]
Review Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL. Dan Med Bull. 2007 May; 54(2):112-39.
Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse. [Biol Blood Marrow Transplant. ...]
Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse.
Yakoub-Agha I, Saule P, Magro L, Cracco P, Duhamel A, Coiteux V, Bruno B, Dufossé F, Jouet JP, Dessaint JP, et al. Biol Blood Marrow Transplant. 2009 Apr; 15(4):496-504. Epub 2009 Feb 12.
Review [Reconstitution kinetics of dendritic cells following allogeneic hematopoietic stem cell transplantation]. [Zhongguo Shi Yan Xue Ye Xue Za...]
Review [Reconstitution kinetics of dendritic cells following allogeneic hematopoietic stem cell transplantation].
Fu HX, Zhang XH. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb; 16(1):222-6.
Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients. [Bone Marrow Transplant. 2006]
Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.
Boeck S, Hamann M, Pihusch V, Heller T, Diem H, Rolf B, Pihusch R, Kolb HJ, Pihusch M. Bone Marrow Transplant. 2006 Jan; 37(1):57-64.
Review Innate immunity against hematological malignancies. [Cytotherapy. 2002]
Review Innate immunity against hematological malignancies.
Ruggeri L, Capanni M, Tosti A, Urbani E, Posati S, Aversa F, Martelli MF, Velardi A. Cytotherapy. 2002; 4(4):343-6.

See reviews... See all...

Cited by 3 PubMed Central articles

Allogeneic stem cell transplantation for rheumatic autoimmune diseases. [F1000 Med Rep. 2010]
Allogeneic stem cell transplantation for rheumatic autoimmune diseases.
Hügle T, van Laar JM. F1000 Med Rep. 2010 Mar 25; 2. Epub 2010 Mar 25.
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age. [Haematologica. 2011]
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age.
Castermans E, Hannon M, Dutrieux J, Humblet-Baron S, Seidel L, Cheynier R, Willems E, Gothot A, Vanbellinghen JF, Geenen V, et al. Haematologica. 2011 Feb; 96(2):298-306. Epub 2010 Oct 7.
Review Stem cell transplantation for rheumatic autoimmune diseases. [Arthritis Res Ther. 2008]
Review Stem cell transplantation for rheumatic autoimmune diseases.
Hügle T, van Laar JM. Arthritis Res Ther. 2008; 10(5):217. Epub 2008 Oct 10.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Reconstitution of adaptive and innate immunity following allogeneic hematopoieti...
Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans.
Cytotherapy. 2006 ;8(5):427-36.

PubMed
Demonstration of the origin of human mast cells from CD34+ bone marrow progenito...
Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells.
J Immunol. 1991 Mar 1 ;146(5):1410-5.

PubMed
The complex role of Fcgamma receptors in the pathology of arthritis.
The complex role of Fcgamma receptors in the pathology of arthritis.
Springer Semin Immunopathol. 2006 Dec ;28(4):339-50. Epub 2006 Oct 17 .

PubMed
Efficient and selective presentation of antigen-antibody complexes by rheumatoid...
Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells.
J Exp Med. 1991 Feb 1 ;173(2):487-9.

PubMed
Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase ...
Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kappaB signaling cascade.
J Cell Biochem. 2007 Apr 1 ;100(5):1217-31.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans.

Source

Abstract

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information